微小面积心肌梗死与常规心肌梗死后的心血管事件风险比较
本研究基于REGARDS前瞻性队列,纳入2003至2015年间发生 incident MI 且无冠心病史的1024名参与者,其中微小面积MI(峰值肌钙蛋白<0.5 ng/mL)328例,常规MI(峰值肌钙蛋白≥0.5 ng/mL)696例。中位随访1.7年后,微小面积MI与常规MI相比,心血管事件的多变量调整HR为1.11(95%CI 0.86-1.44);中位随访3.6年后,全因死亡的多变量调整HR为1.09(95%CI 0.81-1.45)。结论认为微小面积MI对未来心血管事件和死亡的预后价值与常规MI相当。
要点
- 微小面积MI(峰值肌钙蛋白<0.5 ng/mL)与常规MI的心血管事件风险无显著差异。
- 微小面积MI患者全因死亡风险与常规MI相当,HR 1.09(95%CI 0.81-1.45)。
- 临床应像对待常规MI一样,对微小面积MI患者启动二级预防。
核心结论
- 微小面积MI对未来心血管事件和死亡的预后价值与常规MI相当。
研究设计与样本
- REGARDS前瞻性队列分析,纳入2003至2015年间发生 incident MI 且无冠心病史的1024名参与者,其中微小面积MI 328例,常规MI 696例。
主要发现
- 中位随访1.7年后,微小面积MI与常规MI相比,心血管事件的多变量调整HR为1.11(95%CI 0.86-1.44)。
- 中位随访3.6年后,微小面积MI与常规MI相比,全因死亡的多变量调整HR为1.09(95%CI 0.81-1.45)。
- 微小面积MI患者更可能年龄较大且为黑人。
关键数值与推荐
- 微小面积MI定义为峰值肌钙蛋白<0.5 ng/mL,常规MI定义为峰值肌钙蛋白≥0.5 ng/mL。
临床怎么用
- 临床医生应对微小面积MI患者启动二级预防策略,直至对该临床实体有更深入理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microsize myocardial infarction (MI) is a recently described phenomenon that meets rigorous criteria for MI with very low peak troponin elevations. We aim to compare the risk for cardiovascular events and mortality following microsize versus usual MIs. METHODS AND RESULTS: Prospective cohort analysis of REasons for Geographic And Racial Differences in Stroke (REGARDS) study participants without a history of coronary heart disease (CHD) who had an incident MI between 2003 and 2015. Incident MIs were classified as microsize MI (peak troponin <0.5 ng/mL) or usual MI (peak troponin ≥0.5 ng/mL). Participants were followed for a composite of cardiovascular events that included recurrent MI, coronary revascularisation, fatal CHD and heart failure, and all-cause mortality. Overall, 1024 participants with an incident MI were included in the analysis (328 with microsize MI and 696 with usual MI). Participants with microsize MI were more likely to be older and black. The multivariable-adjusted adjustment HR for cardiovascular events among participants with microsize versus usual MI after a median follow-up of 1.7 years was 1.11 (95% CI 0.86 to 1.44). The multivariable-adjusted HR for all-cause mortality after 28 days from incident MI among participants with microsize versus usual MI after a median follow-up of 3.6 years was 1.09 (95% CI 0.81 to 1.45). CONCLUSION: Microsize MIs have a prognostic value for future cardiovascular events and mortality comparable to usual MIs. These findings should encourage clinicians to initiate secondary prevention strategies in patients with microsize MI until this emerging clinical entity is better understood.
引用
- Almarzooq ZI, Colantonio LD, Okin PM, et al. Risk for cardiovascular events following 'microsize' versus usual myocardial infarctions. Heart. 2020. PMID: 33246926. doi:10.1136/heartjnl-2020-317852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。